Proteomic analysis in ob/ob mice before and after hypoglycemic polysaccharide treatments

Journal of Microbiology and Biotechnology

Volumn 19, Issue 10, 2009, Pages 1109-1121

  Kim, Sang Woo ^a   Hwang, Hye Jin ^a   Baek, Yu Mi ^a   Hwang, Hee Sun ^a   Yun, Jong Won ^a  

^a Daegu University   (South Korea)

Author keywords

Diabetes; Ob ob mice; PCR array; Proteome; Tremella fuciformis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; HYPOGLYCEMIA EXTRACELLULAR POLYSACCHARIDE; POLYSACCHARIDE; RETINOL BINDING PROTEIN 4; TRANSFERRIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; DRUG EFFICACY; HYPOGLYCEMIA; LIVER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TREATMENT RESPONSE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BASIDIOMYCOTA; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; PROTEINS; PROTEOMICS; RANDOM ALLOCATION;

MUS; TREMELLA FUCIFORMIS;

EID: 70849124592     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0901.056     Document Type: Article

References (67)

1. Bowers, R. R., J. W. Kim, T. C. Otto, and M. D. Lane. 2006. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: Role of the BMP-4 gene. Proc. Natl. Acad. Sci. U.S.A. 103: 13022-13027.
2. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
3. Cho, E. J., H. J. Hwang, S. W. Kim, J. Y. Oh, Y. M. Baek, J. W. Choi, and J. W. Yun. 2007. Hypoglycemic effects of exopolysaccharides produced by mycelial cultures of two different mushrooms Tremella fuciformis and Phellinus baumii in ob/ob mice. Appl. Microbiol. Biotechnol. 75: 1257-1265.
4. Cho, E. J., J. Y. Oh, H. Y. Chang, and J. W. Yun. 2006. Production of exopolysaccharides by submerged mycelial culture of a mushroom Tremella fuciformis. J. Biotechnol. 127: 129-140. (Pubitemid 46107130)
5. Curtiss, L. K. and W. A. Boisvert. 2000. Apolipoprotein E and atherosclerosis. Curr. Opin. Lipidol. 11: 243-251.
6. Drew, B. G., N. H. Fidge, G. Gallon-Beaumier, B. E. Kemp, and B. A. Kingwell. 2004. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 101: 6999-7004.
7. Ewart, R. B., S. Kornfeld, and D. M. Kipnis. 1975. Effect of lectins on hormone release from isolated rat islets of Langerhans. Diabetes 24: 705-714.
8. Fathman, C. G., L. Soares, S. M. Chan, and P. J. Utz. 2005. An array of possibilities for the study of autoimmunity. Nature 435: 605-611.
9. Gao, X., S. Belmadani, A. Picchi, X. Xu, B. J. Potter, N. Tewari-Singh, S. Capobianco, W. M. Chilian, and C. Zhang. 2007. Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 115: 245-254. (Pubitemid 46105724)
10. Gavi, S., L. M. Stuart, P. Kelly, M. M. Melendez, D. C. Mynarcik, M. C. Gelato, and M. A. McNurlan. 2007. Retinolbinding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J. Clin. Endocrinol. Metab. 92: 1886-1890.
11. Gochukwu, N. H., and N. E. Abady. 2003. Antihyperglycemic effect of aqueous and ethanolic extracts of Gongronema latifolium leaves on glucose and glycogen metabolism in livers of normal and streptozotocin-induced diabetic rats. Life Sci. 73: 1925-1938.
12. Golub, T. R., D. K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J. P. Mesirov, et al. 1999. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
13. Gordon, D. J. and B. M. Rifkind. 1989. High-density lipoprotein - the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
14. Graham, T. E., Q. Yang, M. Bluher, A. Hammarstedt, T. P. Ciaraldi, R. R. Henry, et al. 2006. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354: 2552-2563.
15. Gray, A. M. and P. R. Flatt. 1998. Insulin-releasing and insulinlike activity of Agaricus campestris (mushroom). J. Endocrinol. 157: 259-266.
16. Gude, N., J. Muraski, M. Rubio, J. Kajstura, E. Schaefer, P. Anversa, and M. A. Sussman. 2006. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ. Res. 99: 381-388.
17. Hanniman, E. A., G. Lambert, Y. Inoue, F. J. Gonzalez, and C. J. Sinal. 2006. Apolipoprotein A-IV is regulated by nutritional and metabolic stress: Involvement of glucocorticoids, HNF-4 alpha, and PGC-1 alpha. J. Lipid Res. 47: 2503-2514.
18. Hime, N. J., K. J. Drew, C. Hahn, P. J. Barter, and K. A. Rye. 2004. Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner. Biochemistry 43: 12306-12314.
19. Hirosumi, J., G. Tuncman, L. Chang, C. Z. Gorgun, K. T. Uysal, K. Maeda, M. Karin, and G. S. Hotamisligil. 2002. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336. (Pubitemid 35398190)
20. Hiukkam, A., J. Fruchart-Najib, E. Leinonen, H. Hilden, J. C. Fruchart, and M. R. Taskinen. 2005. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes. Diabetologia 48: 1207-1215.
21. Hu, J. S., M. Durst, R. Kerb, V. Truong, J. T. Ma, E. Khurgin, D. Balaban, T. R. Gingeras, and B. B. Hoffman. 2000. Analysis of drug pharmacology towards predicting drug behavior by expression profiling using high-density oligonucleotide arrays. Ann. N. Y. Acad. Sci. 91: 9-15.
22. Igarashi, M., H. Wakasaki, N. Takahara, H. Ishii, Z. Y. Jiang, T. Yamauchi, et al. 1999. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J. Clin. Invest. 103: 185-195.
23. Iida, S., Y. Sato, A. Nakaya, Y. Shinohara, Y. Hayashi, A. Sawada, et al. 2006. Genome wide expression analysis of white blood cells and liver of pre-diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats using a cDNA microarray. Biol. Pharm. Bull. 29: 2451-2459.
24. Jakupciak, J. P., G. D. Dakubo, S. Maragh, and R. L. Parr. 2006. Analysis of potential cancer biomarkers in mitochondrial DNA. Curr. Opin. Mol. Ther. 8: 500-506.
25. Kawashiri, M. A., C. Maugeais, and D. J. Rader. 2000. Highdensity lipoprotein metabolism: Molecular targets for new therapies for atherosclerosis. Curr. Atheroscler. Rep. 2: 363-372.
26. Kiho, T., A. Yamane, J. Hui, S. Usui, and S. Ukai. 1996. Polysaccharides in fungi. XXXVI. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Biol. Pharm. Bull. 19: 294-296.
27. Kiho, T., H. Morimoto, M. Sakushima, S. Usui, and S. Ukai. 1995. Polysaccharides in fungi. XXXV. Anti diabetic activity of an acidic polysaccharide from the fruiting bodies of Tremella aurantia. Biol. Pharm. Bull. 18: 1627-1629.
28. Kiho, T., Y. Tsujimura, M. Sakushima, S. Usui, and S. Ukai. 1994. Polysaccharides in fungi. XXXIII. Hypoglycemic activity of an acidic polysaccharide (AC) from Tremella fuciformis. Yakugaku Zasshi 114: 308-315.
29. Kim, D. H., B. K. Yang, S. C. Jeong, J. B. Park, S. P. Cho, S. Das, J. W. Yun, and C. H. Song. 2001. Production of a hypoglycemic, extracellular polysaccharide from the submerged culture of the mushroom, Phellinus linteus. Biotechnol. Lett. 23: 513-517.
30. Kim, D. H., B. K. Yang, S. C. Jeong, N. J. Hur, S. Das, J. W. Yun, J. W. Choi, Y. S. Lee, and C. H. Song. 2001. A preliminary study on the hypoglycemic effect of the exopolymers produced by five different medicinal mushrooms. J. Microbiol. Biotechnol. 11: 167-171.
31. Kim, S. W., H. J. Hwang, E. J. Cho, J. Y. Oh, Y. M. Baek, J. W. Choi, and J. W. Yun. 2006. Time-dependent plasma protein changes in streptozotocin- induced diabetic rats before and after fungal polysaccharide treatments. J. Proteome Res. 5: 2966-2976.
32. Kim, S. W., H. J. Hwang, H. M. Kim, M. C. Lee, M. S. Lee, J. W. Choi, and J. W. Yun. 2006. Effect of fungal polysaccharides on the modulation of plasma proteins in streptozotocin-induced diabetic rats. Proteomics 6: 5291-5302. (Pubitemid 44547167)
33. Korc, M. 2003. Diabetes mellitus in the era of proteomics. Mol. Cell Proteomics 2: 399-404.
34. Kotlyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeier, H. D. Volk, and M. Gaestel. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. l: 94-97.
35. Lee, J. H., J. W. Jr. Bullen, V. L. Stoyneva, and C. S. Mantzoros. 2005. Circulating resistin in lean, obese, and insulinresistant mouse models: Lack of association with insulinemia and glycemia. Am. J. Physiol. Endocrinol. Metab. 288: E625-E632.
36. Li, G., E. J. Barrett, M. O. Barrett, W. Cao, and Z. Liu. 2007. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinasedependent pathway. Endocrinology 148: 3356-3363. (Pubitemid 46996990)
37. Mazzone, T. 1996. Apolipoprotein E secretion by macrophages: Its potential physiological functions. Curr. Opin. Lipidol. 7: 303-307.
38. McTernan, P. G., C. L. McTernan, R. Chetty, K. Jenner, F. M. Fisher, M. N. Lauer, J. Crocker, A. H. Barnett, and S. Kumar. 2002. Increased resistin gene and protein expression in human abdominal adipose tissue. J. Clin. Endocrinol. Metab. 87: 2407-2410.
39. Murtaza, I., G. Marra, R. Schlapbach, A. Patrignani, M. Kunzli, U. Wagner, J. Sabates, and A. Dutt. 2006. A preliminary investigation demonstrating the effect of quercetin on the expression of genes related to cell-cycle arrest, apoptosis and xenobiotic metabolism in human CO115 colon-adenocarcinoma cells using DNA microarray. Biotechnol. Appl. Biochem. 45: 29-36.
40. Nadler, S. T., J. P. Stoehr, K. L. Schueler, G. Tanimoto, B. S. Yandell, and A. D. Attie. 2000. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 97: 11371-11376.
41. Neumeier, M., A. Sigruener, E. Eggenhofer, J. Weigert, T. S. Weiss, A. Schaeffler, H. J. Schlitt, C. Aslanidis, and P. Piso. 2007. High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes. Biochem. Biophys. Res. Commun. 352: 543-548.
42. Norata, G. D., M. Ongari, K. Garlaschelli, S. Raselli, L. Grigore, and A. L. Catapano. 2007. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur. J. Endocrinol. 156: 279-284.
43. Olivero, O. A., A. M. Tejera, J. J. Fernandez, B. J. Taylor, S. Das, R. L. Divi, and M. C. Poirier. 2005. Zidovudine induces Sphase arrest and cell cycle gene expression changes in human cells. Mutagenesis 20: 139-146. (Pubitemid 40637814)
44. Ouchi, N., R. Shibata, and K. Walsh. 2006. Cardioprotection by adiponectin. Trends Cardiovasc. Med. 16: 141-146.
45. Rangel-Moreno, J., L. Hartson, C. Navarro, M. Gaxiola, M. Selman, and T. D. Randall. 2006. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Invest. 116: 3183-3194.
46. Ritorto, M. S. and J. Borlak. 2008. A simple and reliable protocol for mouse serum proteome profiling studies by use of two-dimensional electrophoresis and MALDI TOF/TOF mass spectrometry. Proteome Sci. 6: 25.
47. Rumberger, J. M., T. Jr. Peters, C. Burrington, and A. Green. 2004. Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes. Diabetes 53: 2535-2541. (Pubitemid 39299259)
48. Sharma, A., S. Chavali, A. Mahajan, R. Tabassum, R. Banerjee, N. Tandon, and D. Bharadwaj. 2005. Genetic association, posttranslational modification, and protein-protein interactions in type 2 diabetes mellitus. Mol. Cell Proteomics 4: 1029-1037. (Pubitemid 41223363)
49. Sherry, C. L., J. C. O'Connor, J. M. Kramer, and G. G. Freund. 2007. Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. J. Immunol. 178: 663-670.
50. Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68: 850-858.
51. Solinas, G., W. Naugler, F. Galimi, M. S. Lee, and M. Karin. 2006. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl. Acad. Sci. U.S.A. 103: 16454-16459.
52. Sparre, T., R. Bergholdt, J. Nerup, and F. Pociot. 2003. Application of genomics and proteomics in type 1 diabetes pathogenesis research. Expert Rev. Mol. Diagn. 3: 743-757.
53. Sreekumar, R., P. Halvatsiotis, J. C. Schimke, and K. S. Nair. 2002. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51: 1913-1920. (Pubitemid 34564306)
54. Sundsten, T., M. Eberhardson, M. Göransson, and P. Bergsten. 2006. The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes. Proteome Sci. 4: 22.
55. Tan, K. C., S. W. Shiu, Y. Wong, W. K. Wong, and S. Tam. 2006. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus. Diabetes Metab. Res. Rev. 22: 307-312.
56. Tokuyama, Y., H. Osawa, T. Ishizuka, H. Onuma, K. Matsui, T. Egashira, H. Makino, and A. Kanatsuka. 2007. Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism 56: 693-698. (Pubitemid 46574733)
57. Vargas, L., M. E. Kawada, S. Bazaes, P. A. Karplus, and C. H. Faerman. 1998. Insulin antagonism: A novel role for human serum transferrin. Horm. Metab. Res. 30: 113-117.
58. Verges, B., J. M. Petit, L. Duvillard, G. Dautin, E. Florentin, F. Galland, and P. Gambert. 2006. Adiponectin is an important determinant of apoA-I catabolism. Arterioscler. Thromb. Vasc. Biol. 26: 1364-1369.
59. Welsh, J. B., P. P. Zarrinkar, L. M. Sapinoso, S. G. Kern, C. A. Behling, B. J. Monk, D. J. Lockhart, R. A. Burger, and G. M. Hampton. 2001. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 98: 1176-1181.
60. Wolf, G. 2007. Serum retinol-binding protein: A link between obesity, insulin resistance, and type 2 diabetes. Nutr. Rev. 65: 251-256.
61. Yamauchi, T., J. Kamon, H. Waki, Y. Imai, N. Shimozawa, K. Hioki, et al. 2003. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 278: 2461-2468.
62. Yang, Q., T. E. Graham, N. Mody, F. Preitner, O. D. Peroni, J. M. Zabolotny, K. Kotani, L. Quadro, and B. B. Kahn. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362. (Pubitemid 41065039)
63. Yue, L., N. Rasouli, G. Ranganathan, P. A. Kern, and T. Mazzone. 2004. Divergent effects of peroxisome proliferatoractivated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expression. J. Biol. Chem. 279: 47626-47632.
64. Zhang, C. Y., Y. X. Feng, Y. Yu, W. J. Sun, J. Bai, F. Chen, and S. B. Fu. 2006. The molecular mechanism of resistance to methotrexate in mouse methotrexate-resistant cells by cancer drug resistance and metabolism Super Array. Basic Clin. Pharmacol. Toxicol. 99: 141-145.
65. Zhang, H. N., and Z. B. Lin. 2004. Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacol. Sin. 25: 191-195.
66. Zhan, Q., S. Signoretti, D. Whitaker-Menezes, T. M. Friedman, R. Korngold, and G. F. Murphy. 2007. Cytokeratin15-positive basal epithelial cells targeted in graft-versus-host disease express a constitutive antiapoptotic phenotype. J. Invest. Dermatol. 127: 106-115.
67. Zisman, A., O. D. Peroni, E. D. Abel, M. D. Michael, F. Mauvais-Jarvis, B. B. Lowell, et al. 2000. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. 6: 924-928.